Luca Forlani
Research Subjects
Research Interests
Luca Forlani has a total of 11 co-authors. Here are the top co-authors by number of shared publications:
- Andrea Termine
Data Science Unit, Santa Lucia Foundation IRCCS, Rome, Italy
1 shared publication - Carlo Fabrizio
Data Science Unit, Santa Lucia Foundation IRCCS, Rome, Italy
1 shared publication - Debora Varrone
Eurofins Genoma Group, 00138 Rome, Italy
1 shared publication - Emiliano Giardina
Genomic Medicine Laboratory UILDM, IRCCS Santa Lucia Foundation, 00179 Rome, Italy
1 shared publication - Ettore Cotroneo
Eurofins Genoma Group, 00138 Rome, Italy
1 shared publication - Laura Gigante
Eurofins Genoma Group, Laboratory Services in Molecular Genetics, Rome, Italy
1 shared publication
Latest Publications
- Open Access
NIPAT as Non-Invasive Prenatal Paternity Testing Using a Panel of 861 SNVs
In 1997, it was discovered that maternal plasma contains Cell-Free Fetal DNA (cffDNA). cffDNA has been investigated as a source of DNA for non-invasive prenatal testing for fetal pathologies, as well as for non-invasive paternity testing. While the advent of Next Generation Sequencing (NGS) led to the routine use of Non-Invasive Prenatal Screening (NIPT or NIPS), few data are available regarding the reliability and reproducibility of Non-Invasive Prenatal Paternity Testing (NIPPT or NIPAT). Here, we present a non-invasive prenatal paternity test (NIPAT) analyzing 861 Single Nucleotide Variants (SNV) from cffDNA through NGS technology. The test, validated on more than 900 meiosis samples, generated log(CPI)(Combined Paternity Index) values for designated fathers ranging from +34 to +85, whereas log(CPI) values calculated for unrelated individuals were below −150. This study suggests that NIPAT can be used with high accuracy in real cases.
Open AccessNIPAT as Non-Invasive Prenatal Paternity Testing Using a Panel of 861 SNVs
In 1997, it was discovered that maternal plasma contains Cell-Free Fetal DNA (cffDNA). cffDNA has been investigated as a source of DNA for non-invasive prenatal testing for fetal pathologies, as well as for non-invasive paternity testing. While the advent of Next Generation Sequencing (NGS) led to the routine use of Non-Invasive Prenatal Screening (NIPT or NIPS), few data are available regarding the reliability and reproducibility of Non-Invasive Prenatal Paternity Testing (NIPPT or NIPAT). Here, we present a non-invasive prenatal paternity test (NIPAT) analyzing 861 Single Nucleotide Variants (SNV) from cffDNA through NGS technology. The test, validated on more than 900 meiosis samples, generated log(CPI)(Combined Paternity Index) values for designated fathers ranging from +34 to +85, whereas log(CPI) values calculated for unrelated individuals were below −150. This study suggests that NIPAT can be used with high accuracy in real cases.